Arden & GEM is delighted to have been part of a project shortlisted in the pharmacy and medicines optimisation category at the upcoming Health Service Journal (HSJ) Value Awards. The shortlisted project, coordinated by NHS England, looked at new ways of improving value and maximising efficiency to ensure all people living with HIV have access to the most clinically appropriate treatment.
The NHS has developed world class treatment for people living with HIV, meaning patients now have near normal life expectancy as they maintain viral suppression. The impact of delivering lifelong treatment, new HIV diagnoses and the ambition to have all people with HIV on treatment poses a sustainability challenge.
The ‘Improving Value Scheme’ project has successfully optimised the current approach to prescribing anti-retroviral drugs by:
The scheme has been implemented nationally across all HIV services with over 50% of a forecast £22m in savings already achieved.
As part of the project working group, Arden & GEM’s specialist medicines support pharmacist, Rabia Gowa was able to support implementation at a regional level by coordinating communication, engaging local Trust clinical teams, assisting with providing information leaflets, and ensuring correct use of data collection tools. Arden & GEM also managed regional concerns, and suggested solutions to address these concerns, to ensure that the project was a success.
The project team will find out if they have been successful when HSJ Value Awards winners are announced in Manchester on Thursday 7 June.